Sen. Bernie Sanders isn’t alone in his adoration for universal healthcare. According to one recent survey, 56 percent of U.S. doctors are at least somewhat supportive of government-run healthcare.

Their support is somewhat understandable. Every insurer has different administrative requirements, covers different therapies at different levels, and reimburses on a different timeline. Medicare and Medicaid complicate matters further. Dealing with only one insurer — the government — may sound appealing.

. . .

The most significant federal entitlement reform in our lifetime was a little noticed provision that Democrats included in the Affordable Care Act (Obamacare). The provision garnered almost no attention from the mainstream media or even from most conservative commentators. Yet according to the Medicare Trustees report that followed, this one provision eliminated $52 trillion of unfunded federal government liability – an amount that was more than three times the size of the US economy.

. . .

Earlier this week, the Trump administration restored Obama-era rules that allow individuals to buy affordable insurance plans that aren’t bound by Obamacare’s costly regulations. Here’s the low-down on how those plans could affect your insurance choices.

Overcharging the healthy to undercharge the sick

Obamacare’s most significant change to the U.S. health care system was that it introduced an entirely new layer of federal regulations for individuals and families who buy their own health insurance directly, instead of getting it from their employer or from a government program like Medicare or Medicaid. Prior to 2014, these “individual market” or “nongroup” plans were regulated solely at the state level.

. . .

President Trump’s State of the Union address left some declaring that he has “thrown in the towel” on repealing Obamacare. But conversations I’ve had with people in the Trump White House make clear that health care, including Obamacare, remains front-and-center for this administration.

Recently, I spoke with Andrew Bremberg, Director of the President’s Domestic Policy Council, about Trump’s health care agenda for 2018. His view—and his boss’s view—is that the Trump administration has done more than people appreciate on Obamacare, and on health care more broadly. On health care, Trump’s “policy direction is more robust and substantive than some people understand,” Bremberg said.

. . .

Mainstream Democrats are clamoring for Canadian-style single-payer health care — a demand once relegated to the far-left fringe of the party.

Sixteen Senate Democrats, including several with aspirations for the party’s presidential nomination in 2020, have signed onto Sen. Bernie Sanders’s “Medicare for All” plan. Fealty to single-payer is already proving a litmus test for Democrats running for public office in blue states like California.

The increasing idolization of our northern neighbor’s health system is ironic, as Canada’s single-payer system — which I grew up under — just experienced its worst year ever.

. . .

The skyrocketing cost of insurance and diminishing plan choices have driven Americans away from the marketplaces — not presidential malfeasance.

Even before open enrollment started November 1, Obamacare’s proponents tried to lower the public’s expectations and shift blame for the coming drop in enrollees. They predicted that President Trump’s decision to cut Obamacare’s advertising and outreach budget from $100 million to $10 million — as well as his decision to shorten the open enrollment period from 12 to six weeks — would lead to lower enrollment.

The truth is, the administration’s gymnastics have little impact on whether people purchase coverage. Those decisions are dictated by simple things like the price of a plan and how much they value the benefits it provides.

. . .

California’s “Medi-Cal” program is one of the worst offenders when it comes to controlling costs.  It’s getting worse not better.  In fact, Medi-Cal is such a big spender it begs the question what is driving out of control spending in the Golden State – waste, fraud, abuse, incompetence, or all of the above?  Every taxpayer in America should be asking these questions, as we are all footing the majority of the bill.

Over the past ten years, Medicaid spending in California has almost tripled, growing from $37 billion per year to a whopping $103 billion per year—including both state and federal funding. And things have only accelerated since the state expanded Medicaid to a new group of able-bodied adults.

. . .

With debate raging over federal tax reforms, health care has temporarily moved off center stage in U.S. policy debates. But with costs soaring, it won’t stay in the backseat long. Progressives will continue to promote the single-payer idea, with Senator Bernie Sanders and others advocating for “Medicare for All.”

The Affordable Care Act (ACA), also known as Obamacare, is a highly complex law and has made our current health care system more confusing. A single-payer system is attractive to many people because of its perceived simplicity – the U.S. government would provide direct health services to all Americans.

. . .

  • In absolute terms, the average worker in 2016 had to work 63 days a year just to cover his/her own health costs .
  • In relative terms, the average American worker in 2016 must work 9 times as long to cover average health spending costs as his or her counterpart in 1940 .
  • In comparative terms, the average American worker in 2016 must devote roughly twice as many work hours to cover health spending costs as to cover average food costs.

At the 2017 Forbes Healthcare Summit, I interviewed Seema Verma, Administrator of the U.S. Centers for Medicare and Medicaid Services, about her policy agenda. CMS is one of the most important agencies in the federal government, administering programs spending over a trillion dollars a year, including Obamacare.

Our discussion was wide-ranging. Verma spoke about fellow Indianan Alex Azar, President Trump’s nominee for the post of Secretary of the Department of Health and Human Services. She discussed her view of what CMS can do on drug pricing. She talked about the opioid crisis, and how to modernize the Medicare and Medicaid programs and empower patients to take charge of their own health care.

. . .